Emerging Markets Regulatory Tracker: Brazil (Vol. 4 No. 32)
This article was originally published in PharmAsia News
Brazil’s Anvisa is looking at a framework for nanotechnology regulation.
You may also be interested in...
Comments ahead of the vaccine advisory committee ranged from public health groups opposed to emergency use authorizations, to industry requests for guidance on EUA labeling materials.
"One of the issues that COVID-19 has brought out is, how safe is the production of animal-based food products?"
Positive clinical results in Parkinson’s pave path forward for Japanese firm’s potential istradefylline successor.